Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature.

MLA

Oneda, Ester, and Alberto Zaniboni. “Are We Sure That Adjuvant Chemotherapy Is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature.” Journal of Clinical Medicine, vol. 8, no. 11, Nov. 2019, p. 1922. EBSCOhost, https://doi.org/10.3390/jcm8111922.

APA

Oneda, E., & Zaniboni, A. (2019). Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature. Journal of Clinical Medicine, 8(11), 1922. https://doi.org/10.3390/jcm8111922

Chicago

Oneda, Ester, and Alberto Zaniboni. 2019. “Are We Sure That Adjuvant Chemotherapy Is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature.” Journal of Clinical Medicine 8 (11): 1922. doi:10.3390/jcm8111922.